Edwards Lifesciences outlines TMTT growth target of $500M-$530M for 2025 amid strong Q4 performance
Q4 2024 Management View CEO Bernard Zovighian highlighted a strong Q4 2024 performance with total company sales growing 9% year-over-year to $1.39 billion and adjusted earnings per share of $0.59. He ...